Key points from article :
A new longevity-focused startup, Biograph, has emerged from stealth, co-founded by Dr. Peter Attia, a well-known longevity expert, and John Hering, a Silicon Valley entrepreneur and investor. Biograph positions itself as the most advanced preventive health and diagnostics clinic, using over 1,000 data points from 30+ evaluations to provide in-depth health insights. The company aims to help members optimize their health and lifespan through proactive screening and monitoring.
Biograph offers two membership tiers: the Core membership at $7,500 per year and the premium Black membership at $15,000 per year, catering to high-net-worth individuals interested in personalized longevity strategies. The company claims that over 15% of its members have discovered urgent health issues through its services. It has been quietly operating since 2020 and is backed by prominent investors, including Vy Capital, Human Capital, Alpha Wave, and WndrCo.
The inspiration for Biograph stemmed from the cancer diagnosis of Alexander Tamas, a Vy Capital partner, which highlighted the importance of early detection. While the company has not explicitly mentioned AI, it is currently hiring an AI engineer to develop an AI-powered assistant, hinting at future tech-driven health optimization.
Biograph joins a growing wave of longevity startups, including Function Health and Retro Biosciences, both of which have attracted significant funding. With Silicon Valley’s increasing focus on extending healthspan, Biograph represents the latest high-profile venture in the booming longevity sector.
